Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 4

1(25.0%)

4Total

N/A(3)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06197022Not ApplicableUnknown

Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Role: lead

NCT05316753Not ApplicableUnknown

BTE and Pulsed Waveforms for Cardioversion of Atrial Fibrillation - Escalation Strategy and Manual Pressure

Role: lead

NCT04032678Not ApplicableCompleted

Comparison of Efficacy and Safety of Two Biphasic Defibrillators in Cardioversion of Atrial Fibrillation

Role: lead

NCT01724957Unknown

FFR vs. icECG in Coronary Bifurcations

Role: lead

NCT04061525Unknown

Motion and IntraCoronary Ecg Ischemia Development Study (MICE)

Role: lead

NCT02192840Phase 4Completed

POLish Bifurcation Optimal Stenting Study

Role: collaborator

NCT01268228Completed

Intracoronary Electrocardiogram (ECG) and Myonecrosis After Bifurcation Stenting

Role: lead

All 7 trials loaded